Efg Asset Management (North America) Corp. Axonics, Inc. Transaction History

Efg Asset Management (North America) Corp.

$585 Million
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$49.38 - $63.75 $42,071 - $54,315	-852 Reduced 2.42%	34,302 $2.13 Million
Q3 2023 Nov 02, 2023	BUY	$48.64 - $62.51 $278,172 - $357,494	5,719 Added 19.43%	35,154 $1.97 Million
Q2 2023 Jul 28, 2023	BUY	$47.99 - $60.21 $146,417 - $183,700	3,051 Added 11.56%	29,435 $1.49 Million
Q1 2023 Apr 27, 2023	BUY	$52.6 - $67.34 $334,483 - $428,215	6,359 Added 31.76%	26,384 $1.44 Million
Q4 2022 Feb 03, 2023	SELL	$59.56 - $76.6 $596,374 - $766,995	-10,013 Reduced 33.33%	20,025 $1.25 Million
Q3 2022 Oct 28, 2022	SELL	$57.96 - $78.12 $688,564 - $928,065	-11,880 Reduced 28.34%	30,038 $2.12 Million
Q2 2022 Aug 04, 2022	SELL	$39.5 - $64.42 $142,081 - $231,718	-3,597 Reduced 7.9%	41,918 $2.38 Million
Q1 2022 Apr 26, 2022	BUY	$43.74 - $62.76 $236,720 - $339,657	5,412 Added 13.5%	45,515 $2.85 Million
Q4 2021 Feb 18, 2022	BUY	$50.01 - $73.35 $2.01 Million - $2.94 Million	40,103 New	40,103 $2.25 Million

Others Institutions Holding AXNX

# of Institutions

233

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

Vanguard Group Inc Valley Forge, PA

5.06M
Shares

$359 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.34M
Shares

$308 Million
0.01% of portfolio
Alpine Associates Management Inc. Englewood Cliffs, NJ

2.18M
Shares

$155 Million
6.99% of portfolio
Fil LTD Hamilton, D0

2.04M
Shares

$145 Million
0.14% of portfolio
Westchester Capital Management, LLC Valhalla, NY

1.45M
Shares

$103 Million
4.89% of portfolio

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.

Account